Table 4.
Univariate regression analysis of factors associated with likelihood of using a permanent access at initiation dialysis in patients with predialysis arteriovenous fistula surgery
| Factor | Odds Ratio | 95% Confidence Interval | P Value |
|---|---|---|---|
| Age, ≥65 versus <65 yr old | 1.38 | 0.75 to 2.52 | 0.30 |
| Sex, women versus men | 0.79 | 0.46 to 1.36 | 0.40 |
| Race, black versus white | 0.84 | 0.46 to 1.55 | 0.58 |
| Diabetes, yes versus no | 0.95 | 0.54 to 1.67 | 0.86 |
| CAD, yes versus no | 1.44 | 0.78 to 2.65 | 0.24 |
| PVD, yes versus no | 1.55 | 0.71 to 3.42 | 0.27 |
| CHF, yes versus no | 1.02 | 0.57 to 1.82 | 0.95 |
| Access location, forearm versus upper arm | 1.02 | 0.59 to 1.76 | 0.94 |
| Arterial diameter per mm | 0.96 | 0.72 to 1.29 | 0.80 |
| Vein diameter per mm | 1.02 | 0.83 to 1.25 | 0.86 |
| eGFR at AVF surgery per 5 ml/min per 1.73 m2 | 1.26 | 0.92 to 1.72 | 0.14 |
| GFR trajectory per 3 ml/min per 1.73 m2 per yr | 0.93 | 0.85 to 1.02 | 0.14 |
| Urine protein-to-creatinine ratioa per 1 U | 0.95 | 0.86 to 1.04 | 0.25 |
| Systolic BP per 10 mmHg | 0.96 | 0.86 to 1.08 | 0.53 |
CAD, coronary artery disease; PVD, peripheral vascular disease; CHF, congestive heart failure; AVF, arteriovenous fistula.
a
Both urine protein and urine creatinine are in milligrams per deciliter.